GENESISBiotechnology

Genesis IBRC India LtdPE Ratio & Valuation Analysis

98.98
+0.00%
Current P/EN/AxPrice to earnings
Industry P/E51.82xSector average
100.0% Discount to Industry
GENESIS P/E N/Ax vs sector avg 51.82x
💡

Understanding Genesis IBRC India Ltd Valuation

Genesis IBRC India Ltd (GENESIS) currently trades at N/Ax earnings. The Biotechnology sector average PE is 51.82x. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.

ROE
51.62%
Dividend Yield
0.00%

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.